• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
BlackDoctor.org
Where Wellness & Culture Connect

Where Wellness & Culture Connect

  • Conditions
  • Wellness
  • Lifestyle
  • Longevity
  • Clinical Trials
  • Resources
    • Generational Health
    • Top Blacks in Healthcare 2025
    • Hall Of Fame
    • Clinical Trials Resource Center
    • Obesity Resource Center
    • Cancer Resource Center
    • Wellness on the Yard
    • Immunocompromised Care
    • BDO Resource Library
  • Find A Doctor
  • BDO TV
Home / Health Conditions / Leukemia / Childhood Cancer Survivors Living Longer But Not Always Better

Childhood Cancer Survivors Living Longer But Not Always Better

 

black woman sitting on the edge of her bed in painDespite three decades of advancements in treating children with cancer, patients who survive into adulthood don’t report better physical or mental health than their counterparts who were treated years ago, researchers report.

Adults treated as children in the 1990s were more likely to report poor general health and anxiety than adults treated as children in the 1970s, the researchers said.

That’s not what the researchers had expected to find. After all, patients are living longer today than in past generations. More than 80 percent of children diagnosed with cancer are alive at least five years after their diagnosis, the U.S. National Cancer Institute says.

You May Also Like
Psoriatic Arthritis Can Feel Beyond Your Control. Consider a Different Direction. Learn More Here. Psoriatic Arthritis Can Feel Beyond Your Control. Consider a Different Direction. Learn More Here.

And there have been significant efforts to minimize the toxic side effects of cancer treatments. Proton therapy limits radiation damage to healthy tissue, while limb-sparing surgery has largely replaced amputation, noted Kirsten Ness, a physical therapist and one of the study authors.

“I kept looking at the data, thinking, ‘This can’t be right,’ ” said Ness, a faculty member in the Department of Epidemiology and Cancer Control at St. Jude Children’s Research Hospital in Memphis, Tenn.

“We were sort of expecting that they wouldn’t have as many problems with their perceived health as survivors who were treated in earlier generations,” she said.

You May Also Like
Get GLP-1s Delivered to You As Low As $99/Month! Get GLP-1s Delivered to You As Low As $99/Month!

Pam Gabris is coordinator for Beyond the Cure, a program of the National Children’s Cancer Society (NCCS) in St. Louis. Beyond the Cure prepares survivors and their families for life after cancer.

While the study results are “disappointing,” survivors’ awareness of potential complications, or “late effects,” of cancer treatment is improving, according to Gabris, a registered nurse.

“Now we have to provide the tools they need to manage their health,” she said.

NCCS, for example, offers an online tool that allows survivors to plug in information about their cancer and view specific information on potential late effects they may experience, symptoms, prevention tips and recommendations for follow-up care.

Two-thirds of all survivors experience one or more late effects from their disease, their treatment or both, NCCS says.

There are an estimated 15.5 million cancer survivors in the United States, the National Cancer Institute reports.

For the new review, led by St. Jude, researchers from Toronto and across the United States reviewed information from the Childhood Cancer Survivor Study. This is a long-term, multi-hospital study that captures data from survivors’ medical records.

The study originally included patients diagnosed between 1970 and 1986 and recently was expanded to include patients who received a diagnosis between 1987 and 1999.

The research involved more than 14,500 adults, now ages 18 to 48, who survived five or more years after diagnosis. All were treated as children between 1970 and 1999.

The analysis relied on patients’ own reports of their overall physical and mental health, ability to function, activity limitations and cancer-related anxiety or pain.

The proportion of patients reporting severe, disabling or life-threatening chronic conditions declined from more than 33 percent among those treated from 1970 to 1979 to 21 percent among those who were treated from 1990 to 1999.

Yet reports of adverse health outcomes did not decline by generation.

Leukemia and osteosarcoma (cancer of the bone) survivors, in particular, reported sharply higher rates of adverse outcomes.

More than a third (37 percent) of osteosarcoma patients treated in the ’90s reported cancer-related pain, for example. For those osteosarcoma patients treated in the ’70s, about a quarter (24 percent) said they had cancer-related pain.

The lingering pain may be related to limb-sparing surgery, leading to multiple limb-lengthening procedures as kids grow, Ness said. Or, it could be the result of deformities that cause people to walk with a limp, she said.

Some survivors reported significant difficulty getting around or performing day-to-day activities.

Anxiety was also a problem. Ness suspects that the younger generation, unlike children of the ’70s and ’80s, are given permission to worry.

It’s possible today’s survivors “truly have worse outcomes,” since more people who would have died in previous generations are beating higher-risk disease, Ness reasoned. It may also be that they have expectations of a higher quality of life.

Ness said the findings can help inform future clinical trials, with the goal of devising treatments that are less toxic. The study also points to the need for better follow-up care, including treatment for smoking, drinking, lack of exercise and poor diet, which were associated with adverse health outcomes in the study.

The study was funded in part through a grant from the U.S. National Cancer Institute. The findings were published Nov. 7 in the Annals of Internal Medicine.

 

By Derrick Lane | Published November 8, 2016

November 8, 2016 by HealthDay News

The Latest In Leukemia

chronic myeloid leukemia

Chronic Myeloid Leukemia: From 3 Years to Live to 30 Years of Survival

In January 1995, at the age of 37, my life changed forever. As an active Army officer, husband, and father to a five-year-old daughter, I was diagnosed with chronic myeloid leukemia (CML). The prognosis was grim—an average survival time of read more about Chronic Myeloid Leukemia: From 3 Years to Live to 30 Years of Survival
A Black Hematologist Shares How We Can Improve Outcomes For Blood Cancer Patients

A Black Hematologist Shares How We Can Improve Outcomes For Blood Cancer Patients

Blood cancers, such as leukemia, lymphoma, and multiple myeloma, disproportionately affect Black Americans. According to Dr. Ruemu Birhiray, a hematology-oncologist at American Oncology Partners in Indianapolis, Black people make up about 14 percent of the U.S. population but account for read more about A Black Hematologist Shares How We Can Improve Outcomes For Blood Cancer Patients

Lifestyle Changes After Chronic Myeloid Leukemia (CML) Treatment

It’s hard readjusting to daily activities after undergoing treatment for chronic myeloid leukemia (CML), a blood and bone marrow disease. You’re not alone. About 1 in 526 people will get CML in their lifetime, according to the American Cancer Society read more about Lifestyle Changes After Chronic Myeloid Leukemia (CML) Treatment
New Ready-Made Treatment for Acute Myeloid Leukemia Presented at AACR Chicago

New Ready-Made Treatment for Acute Myeloid Leukemia Presented at AACR Chicago

Scientists have developed a new, ready-made way to fight blood cancers that looks promising. Imagine having cancer-fighting cells already prepared and waiting, ready to be given to patients who need them. The results were presented at the American Association for read more about New Ready-Made Treatment for Acute Myeloid Leukemia Presented at AACR Chicago
Ask a Black Doctor: Navigating Chronic Myeloid Leukemia

Ask a Black Doctor: Navigating Chronic Myeloid Leukemia

Chronic myeloid leukemia (CML), a slow-growing blood cancer, affects people of all backgrounds, but understanding its nuances within the Black community is crucial. While less common than some other cancers, CML presents unique challenges for Black patients, including potential disparities read more about Ask a Black Doctor: Navigating Chronic Myeloid Leukemia
This Clinical Trial Helped Hard-to-Treat Leukemia

This Clinical Trial Helped Hard-to-Treat Leukemia

(HealthDay News) — A newly approved immunotherapy can help adults with a difficult-to-treat form of leukemia, clinical trial results show. Aucatzyl (obecabtagene autoleucel) worked on more than three-quarters (76%) of patients with B-cell acute lymphoblastic leukemia (ALL), and more than half read more about This Clinical Trial Helped Hard-to-Treat Leukemia

Primary Sidebar

Subscribe to our newsletter

Icon

Caring for You, Too - Caregiver Workbook

1 file(s) 297 KB
Download

Trending Articles

10 Foods Your Liver Wishes You Would Would Stop Eating

healthy liver

10 Foods That Naturally Lower Cholesterol

foods that lower cholesterol

9 Black Women Who Prove ’50+ Is The New 30′

50 year old black woman

Secrets For A Non-Damaging Silk Press

silk press

The 5 Levels Of Caregiving

caregiving
Find a Culturally Sensitive Doctor

Footer

Where Wellness & Culture Connect

BDO is the world’s largest and most comprehensive online health resource specifically targeted to African Americans. BDO understands that the uniqueness of Black culture - our heritage and our traditions - plays a role in our health. BDO gives you access to innovative new approaches to the health information you need in everyday language so you can break through the disparities, gain control and live your life to its fullest.

Connect With Us

Resource Centers

  • Top Blacks in Healthcare
  • Clinical Trials
  • Wellness on the Yard
  • Cancer
  • Immunocompromised Care
  • About Us
  • Privacy Policy
  • Cookie Policy
  • Terms of Service
  • Careers
  • Advertise With Us
  • Advertising & Sponsorship Policy
  • Daily Vitamina
  • TBH

Copyright © 2025, Black Doctor, Inc. All rights reserved.